Financial reports
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
13 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
11 Mar 22
Current reports
8-K
Myomo Appoints Heather Getz to its Board of Directors
28 Mar 24
8-K
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
7 Mar 24
8-K
Other Events
1 Mar 24
8-K
Departure of Directors or Certain Officers
22 Feb 24
8-K
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
17 Jan 24
8-K
Departure of Directors or Certain Officers
19 Dec 23
8-K
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations
7 Nov 23
8-K
CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting
6 Nov 23
8-K
Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category
2 Nov 23
8-K
Entry into a Material Definitive Agreement
28 Aug 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
17 Jan 24
424B5
Prospectus supplement for primary offering
28 Aug 23
424B5
Prospectus supplement for primary offering
24 Aug 23
424B5
Prospectus supplement for primary offering
24 Aug 23
S-8
Registration of securities for employees
28 Jun 23
424B4
Prospectus supplement with pricing info
13 Jan 23
S-1MEF
Registration of additional securities for an S-1
11 Jan 23
S-1/A
IPO registration (amended)
10 Jan 23
S-1/A
IPO registration (amended)
10 Jan 23
S-1/A
IPO registration (amended)
4 Jan 23
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
28 Oct 22
PRE 14A
Preliminary proxy
18 Oct 22
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEF 14A
Definitive proxy
28 Apr 21
PRE 14A
Preliminary proxy
16 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
Other
EFFECT
Notice of effectiveness
17 Jan 23
EFFECT
Notice of effectiveness
26 May 21
CORRESP
Correspondence with SEC
21 May 21
UPLOAD
Letter from SEC
20 May 21
EFFECT
Notice of effectiveness
11 Feb 20
CORRESP
Correspondence with SEC
6 Feb 20
CORRESP
Correspondence with SEC
6 Feb 20
UPLOAD
Letter from SEC
10 Jan 20
CORRESP
Correspondence with SEC
30 Dec 19
UPLOAD
Letter from SEC
23 Dec 19
Ownership
4
Harry Kovelman
4 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
3
Heather C Getz
28 Mar 24
4
THOMAS F KIRK
18 Mar 24
4
DAVID A HENRY
13 Mar 24
4
Harry Kovelman
13 Mar 24
4
Micah Mitchell
13 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
144
Notice of proposed sale of securities
11 Mar 24